Target discovery

Vaiomer studies the relationship between tissue microbiota and host genes to identify new therapeutic targets for drug development.

Vaiomer has established a unique technology platform for new target discovery based on specific tools developed and optimized in house including:

  • Human clinical cohorts
  • Animal models
  • State of the art molecular biology and multi-omics techniques
  • Bioinformatic tools

Our skills in physiology, molecular biology, and bioinformatics are leveraged to elucidate the complex interaction networks involving bacterial taxa, bacterial functions, host gene expression and host metabolism to allow the identification of refined new therapeutic targets. These targets can be used to develop new chemical entities (NCEs) as pharmaceutical drugs or to reshape existing drugs for new indications.

Gene Network

Host genes co-variance in mouse adipose tissue. 


Need more information ? You are welcome to contact our experts